The Worldwide Innovative Network (WIN) Consortium,  brings together 28 world-class institutions spanning 19 countries and 5 continents. This non-profit organization, under the leadership of the late John Mendelsohn and Thomas Tursz, focuses on launching trials using its biomarker platform to advance Precision Oncology globally. WIN symposia in Precision Oncology are organized by WIN, aiming to deepen participants' understanding of cancer biomarkers for diagnostics, prognostics, and predictions. This initiative addresses issues of access, diversity, and equity in precision oncology, targeting stakeholders in cancer research, technology development, and patient management, including medical oncologists, hematologists, surgical oncologists, pathologists, researchers, and industry officials.

 [Read on win-burjeel-symposium](https://www.menaconference.com/events/win24/registration/)

Continue reading at menaconference.com

Health and Wellness

Facebook Share

Twitter Share

Linkedin Share

Email Share